Replies to post #2955 on Celsion Corporation (CLSN)

[Bangkok Bob]

that preempt much covers it..

well done

[Chabojilo]

Naturally, everyday, if you're wondering about trade plays, you should analyze charts and daily trading trends. I'm not scoffing at the process of determining whether or not you want to make a play at a certain target. I'm open for the analysis and that it what I was pointing out regarding this gap-fill expectation.

This is the point of re-examining the 'Market Cap' situation and how the market cap evolves as new information comes to light.

The Phillips collaboration is intriguing, and the goal for the bone metastases study is only Pain reduction. This, to me, seems like an easy target. They also have the non-invasive HIFU trials coming with Pancreatic cancer and metastatic liver cancer.

We also have the potential validation to TDox when we hear 'remarkable' clinical updates for the RCW trial, from Vienna in September.

Dr. Blackwell, who is involved in the RCW trial, was at ASCO this year for the Roche EMILIA trial presentation. Dr. Blackwell at ASCO

Dr. Solomon from the ABLATE study was also at ASCO covering colorectal liver mets. ASCO briefs

CLSN pps began its surge the Monday morning the 4th of June after the weekend of ASCO 2012. People at ASCO must have heard good things about the Doctors' experience with TDox in treating cancer.

The float is only 28.8 million, for the potential in TDox, the market cap should begin to establish support at higher levels. Look at the options plays recently, Institutions are going to want shares. Someone must be thinking about that potential DEMAND for shares, with a short supply. I'm thinking any potential dilution over 5$ would be grabbed in an instant.

I wouldn't be surprised to see a substantial sell off next week at some point, maybe to try to trigger stop losses, maybe to short and take profit, but I also think people will step in to set large blocks at the bid to gobble up cheaper shares.

Look at the trading during the last 2 minutes on Friday.
95,000 shares hitting the ask price, 12,000 shares hitting the bid price. Traders were buying late not dumping.